Ivor Royston is CEO & President at Viracta Therapeutics, Inc. (VIRX). They have made 10 open-market trades across 4 companies since 2006, most recently 2024-11-25.
CIK 0001026765
7 open-market purchases totalling $8.2M since 2006, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIRX | SELL | 2022-08-26 | 2022-08-29 | $4.01 | $107K | +29.8% | +7.6% | -37.9% |
| VIRX | SELL | 2022-05-26 | 2022-05-27 | $1.90 | $25K | +50.7% | +51.2% | +98.1% |
| VIRX | SELL | 2022-02-28 | 2022-03-01 | $2.78 | $41K | -12.8% | +68.8% | -24.8% |
| VIRX | BUY | 2021-11-15 | 2021-11-15 | $5.56 | $44K | -17.1% | -38.9% | -52.4% |
| SNDX | BUY | 2016-03-08 | 2016-03-08 | $12.00 | $1.8M | -14.7% | +21.6% | +2.2% |
| BIOC | BUY | 2015-03-16 | 2017-03-29 | $8.76 | $50K | -12.7% | -23.9% | -34.3% |
| BIOC | BUY | 2015-02-13 | 2015-02-18 | $1.25 | $15K | -13.9% | -0.5% | -0.5% |
| FVRL | BUY | 2006-12-29 | 2007-01-03 | $2.63 | $105K | N/A | N/A | N/A |
| FVRL | BUY | 2006-12-27 | 2006-12-28 | $2.52 | $97K | N/A | N/A | N/A |
| FVRL | BUY | 2006-03-07 | 2006-03-09 | $5.26 | $6.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.